¼¼°èÀÇ ¾ÈÀüħ ½ÃÀå
Safety Needles
»óǰÄÚµå : 1763279
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 529 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,225,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,675,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ¾ÈÀüħ ½ÃÀåÀº 2030³â±îÁö 43¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 29¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ¾ÈÀüħ ½ÃÀåÀº 2024-2030³â¿¡ CAGR 6.9%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 43¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ¾×Ƽºê´Â CAGR 7.3%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 32¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÆÐ½Ãºê ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 5.7%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 7¾ï 4,070¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 10.2%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¾ÈÀüħ ½ÃÀåÀº 2024³â¿¡ 7¾ï 4,070¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 10¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 10.2%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 3.4%¿Í 6.3%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¾ÈÀüħ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¾ÈÀüħÀº ÀÇ·á Á¾»çÀÚ¿Í È¯ÀÚ¸¦ ¹Ù´Ã¿¡ Âñ¸®´Â ºÎ»ó°ú ±×¿¡ µû¸¥ Ç÷¾× À¯·¡ º´¿øÃ¼ °¨¿°ÀÇ À§ÇèÀ¸·ÎºÎÅÍ º¸È£Çϱâ À§ÇØ °í¾ÈµÈ ÀÇ·á±â±âÀÔ´Ï´Ù. ÀÌ ¹Ù´ÃÀº »ç¿ë ÈÄ Áï½Ã ÀÛµ¿µÇ´Â ¼ö³³½Ä ¶Ç´Â Â÷ÆóÇü ¹Ù´Ã°ú °°Àº ¾ÈÀü ±â´ÉÀ» °®Ãß°í ÀÖÀ¸¸ç, ½Ç¼ö·Î ¹Ù´Ã¿¡ Âñ¸®´Â °ÍÀ» ¹æÁöÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾ÈÀüħÀÇ Ã¤ÅÃÀº ¾ö°ÝÇÑ ±ÔÁ¦¿Í Á÷Àå ¾ÈÀü °­È­ÀÇ Çʿ伺À¸·Î ÀÎÇØ ÀÇ·á ÇöÀå¿¡¼­ Áß¿äÇÑ ¿ä¼Ò·Î ÀÚ¸® Àâ¾Ò½À´Ï´Ù. ¾ÈÀü¹Ù´ÃÀº ÁÖ»ç, äÇ÷, Á¤¸Æ Ä«Å×ÅÍ »ðÀÔ µî ´Ù¾çÇÑ ÀÇ·áÇàÀ§¿¡ »ç¿ëµË´Ï´Ù. ¾ÈÀü¹Ù´ÃÀº ħ¿¡ Âñ¸®´Â ºÎ»óÀÇ À§ÇèÀ» ÃÖ¼ÒÈ­ÇÏ¿© HIV, BÇü °£¿°, CÇü °£¿°°ú °°Àº º´¿ø±Õ¿¡ ÀÇÇÑ °¨¿° ¹ß»ý·üÀ» ³·Ãß¾î ÀÇ·áÁø°ú ȯÀÚ¿¡°Ô ½É°¢ÇÑ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¾ÈÀüħÀÇ µðÀÚÀΰú ±â´É¼ºÀ» Å©°Ô Çâ»ó½ÃÄ×½À´Ï´Ù. ÃֽоÈÀüħÀº ÀÚµ¿ ¼öÃà, ÆÐ½Ãºê ½¯µå, ÇÑ ¼ÕÀ¸·Î ½±°Ô Á¶ÀÛÇÒ ¼ö ÀÖ´Â ±â´É µîÀ» µµÀÔÇÏ¿© »ç¿ë ÆíÀǼº°ú ¾ÈÀü¼ºÀ» Çâ»ó½ÃÄ×½À´Ï´Ù. Àç·á °úÇÐÀÇ ¹ß´Þ·Î ´õ ¾ÈÀüÇÒ »Ó¸¸ ¾Æ´Ï¶ó ȯÀÚ¿¡°Ô ´õ Æí¾ÈÇÑ Ä§À» °³¹ßÇÏ¿© ÃʹÚÇü º®°ú À±È° ÄÚÆÃÀ» ÅëÇØ ÅëÁõ°ú Á¶Á÷ ¼Õ»óÀ» ÁÙ¿´½À´Ï´Ù. ¶ÇÇÑ ¹Ù´ÃÀÇ ¼º´ÉÀ» ¹æÇØÇÏÁö ¾Ê°í »ç¿ëÀÇ º¹À⼺À» Áõ°¡½ÃŰÁö ¾Ê´Â ¾ÈÀü ¸ÞÄ¿´ÏÁòÀÇ ÅëÇÕÀÌ Áß¿äÇÑ ÃÊÁ¡ÀÌ µÇ¾î ÀÇ·áÁøÀÌ Ãß°¡ ±³À° ºÎ´ã ¾øÀÌ ÀÌ·¯ÇÑ ±â±¸¸¦ äÅÃÇÒ ¼ö ÀÖµµ·Ï Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÎü°øÇÐÀû ¼³°è¿¡ ´ëÇÑ °­Á¶´Â »ç¿ëÀÚÀÇ Æí¾ÈÇÔÀ» Çâ»ó½Ã۰í ÀÇ·áÁøÀÇ ¹Ýº¹ÀûÀÎ ÇÇ·Î ¼Õ»óÀÇ À§ÇèÀ» °¨¼Ò½ÃŰ´Â µ¥ µµ¿òÀÌ µÇ¾ú½À´Ï´Ù.

¾ÈÀüħ ½ÃÀåÀÇ ¼ºÀåÀº ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç, Á÷¾÷Àû À§Çè¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ÀæÀº Áֻ縦 ÇÊ¿ä·Î ÇÏ´Â ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. Àü ¼¼°è ±ÔÁ¦±â°üÀº ÀÇ·á ÇöÀå¿¡¼­ ÀÏÇÏ´Â »ç¶÷µéÀ» ¹Ù´Ã¿¡ Âñ¸®´Â ºÎ»óÀ¸·ÎºÎÅÍ º¸È£Çϱâ À§ÇØ ¾ÈÀü ¹Ù´Ã »ç¿ëÀ» Àǹ«È­Çϰí ÀÖÀ¸¸ç, ÀÌ´Â º¸±ÞÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. »ê¾÷ ¾ÈÀü º¸°Ç¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ÀÇ·á ±â°üÀÌ º¸´Ù ¾ÈÀüÇÑ ÀÛ¾÷ ȯ°æÀ» Á¦°øÇϱâ À§ÇØ ³ë·ÂÇÏ´Â °¡¿îµ¥ ÀÌ·¯ÇÑ Àåºñ¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Á¤±âÀûÀÎ Àν¶¸° Áֻ縦 ÇÊ¿ä·Î ÇÏ´Â ´ç´¢º´°ú °°Àº ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ´Ù¾çÇÑ Áúȯ¿¡ ´ëÇÑ ÁÖ»ç °¡´ÉÇÑ »ý¹°Á¦Á¦ÀÇ »ç¿ë Áõ°¡´Â ¾ÈÀü ¹Ù´Ã¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåºñÀÇ ¾ÈÀü¼º°ú »ç¿ë ÆíÀǼºÀ» Çâ»ó½ÃŰ´Â ±â¼ú ¹ßÀü°ú ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡µµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(¾×ƼºêÇü, ÆÐ½ÃºêÇü); ÃÖÁ¾»ç¿ëÀÚ(º´¿ø¡¤¿Ü·¡ ¼ö¼ú ¼¾ÅÍ, ´ç´¢º´ ȯÀÚ, ÆÐ¹Ð¸® ÇÁ·¢Æ¼½º, Á¤½Å°ú, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Safety Needles Market to Reach US$4.3 Billion by 2030

The global market for Safety Needles estimated at US$2.9 Billion in the year 2024, is expected to reach US$4.3 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Active, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$3.2 Billion by the end of the analysis period. Growth in the Passive segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$740.7 Million While China is Forecast to Grow at 10.2% CAGR

The Safety Needles market in the U.S. is estimated at US$740.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 10.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Safety Needles Market - Key Trends & Drivers Summarized

Safety needles are medical devices designed to protect healthcare workers and patients from needlestick injuries and the associated risks of bloodborne pathogen transmission. These needles are equipped with safety features such as retractable or shielded needles that activate immediately after use, preventing accidental sticks. The adoption of safety needles has become a critical component in healthcare settings, driven by stringent regulations and the need to enhance workplace safety. These devices are used in various medical procedures, including injections, blood draws, and IV catheter placements. By minimizing the risk of needlestick injuries, safety needles help reduce the incidence of infections from pathogens such as HIV, hepatitis B, and hepatitis C, which can have serious implications for healthcare workers and patients alike.

Technological advancements have significantly improved the design and functionality of safety needles. Modern safety needles incorporate features such as automatic retraction, passive shielding, and easy one-handed operation, enhancing usability and safety. Advances in materials science have led to the development of needles that are not only safer but also more comfortable for patients, with ultra-thin walls and lubricated coatings that reduce pain and tissue damage. Additionally, the integration of safety mechanisms that do not interfere with the needle's performance or increase the complexity of use has been a key focus, ensuring that healthcare workers can adopt these devices without additional training burdens. The increased emphasis on ergonomic designs has also improved user comfort and reduced the risk of repetitive strain injuries among healthcare providers.

The growth in the safety needles market is driven by several factors, including stringent regulatory requirements, increasing awareness of occupational hazards, and the rising incidence of chronic diseases requiring frequent injections. Regulatory bodies worldwide have mandated the use of safety needles in healthcare settings to protect workers from needlestick injuries, driving widespread adoption. The heightened awareness of occupational health and safety has also spurred demand for these devices, as healthcare institutions strive to provide safer working environments. The rising prevalence of chronic conditions such as diabetes, which necessitates regular insulin injections, and the increased use of injectable biologics for various medical conditions, have further boosted the demand for safety needles. Technological advancements that enhance the safety and usability of these devices, coupled with growing investments in healthcare infrastructure, are also contributing to market growth.

SCOPE OF STUDY:

The report analyzes the Safety Needles market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Active, Passive); End-Use (Hospitals & Ambulatory Surgery Centers, Diabetic Patients, Family Practices, Psychiatry, Other End-Uses)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 101 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â